Bristol-Myers Squibb
BMY
#187
Rank
C$172.13 B
Marketcap
C$84.27
Share price
-0.77%
Change (1 day)
34.70%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): C$6.35

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is C$6.47. In 2025 the company made an earnings per share (EPS) of C$4.93 an increase over its 2024 EPS that were of C-$6.30.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$6.3528.8%
2025C$4.93-178.28%
2024C-$6.30-213.92%
2023C$5.5330.2%
2022C$4.25-6.04%
2021C$4.52-179.29%
2020C-$5.70-281.37%
2019C$3.14-27.21%
2018C$4.32
2016C$3.81175.26%
2015C$1.38-19.83%
2014C$1.72-22.44%
2013C$2.2234.48%
2012C$1.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.45 92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.49 46.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.08-83.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$5.09-21.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.60 558.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$23.12 257.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.71-58.09%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$8.10 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.80-72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$9.52 47.14%๐Ÿ‡ฌ๐Ÿ‡ง UK